Anti-fungal Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: A064D9F5CD05EN
Market Monitor Global

Abstracts

Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.

This report contains market size and forecasts of Anti-fungal Drugs in Global, including the following market information:

Global Anti-fungal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-fungal Drugs market was valued at 1770.4 million in 2021 and is projected to reach US$ 2075.4 million by 2028, at a CAGR of 2.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-fungal Drugs include Abbott Laboratories, Astellas Pharma, Bayer, GlaxoSmithKline, Glenmark, Kramer Laboratories, Merck, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-fungal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-fungal Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-fungal Drugs Market Segment Percentages, by Type, 2021 (%)

• Powder
• Ointment
• Tablet
• Other

Global Anti-fungal Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-fungal Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacy
• Online Pharmacy

Global Anti-fungal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-fungal Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-fungal Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-fungal Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Astellas Pharma
• Bayer
• GlaxoSmithKline
• Glenmark
• Kramer Laboratories
• Merck
• Novartis
• Pfizer
• SCYNEXIS
• Sanofi
• Gilead Science
• Enzon Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-fungal Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-fungal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-FUNGAL DRUGS OVERALL MARKET SIZE

2.1 Global Anti-fungal Drugs Market Size: 2021 VS 2028
2.2 Global Anti-fungal Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-fungal Drugs Players in Global Market
3.2 Top Global Anti-fungal Drugs Companies Ranked by Revenue
3.3 Global Anti-fungal Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-fungal Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-fungal Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-fungal Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Anti-fungal Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-fungal Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-fungal Drugs Market Size Markets, 2021 & 2028
  4.1.2 Powder
  4.1.3 Ointment
  4.1.4 Tablet
  4.1.5 Other
4.2 By Type - Global Anti-fungal Drugs Revenue & Forecasts
  4.2.1 By Type - Global Anti-fungal Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Anti-fungal Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Anti-fungal Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-fungal Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Anti-fungal Drugs Revenue & Forecasts
  5.2.1 By Application - Global Anti-fungal Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Anti-fungal Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Anti-fungal Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-fungal Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-fungal Drugs Revenue & Forecasts
  6.2.1 By Region - Global Anti-fungal Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Anti-fungal Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Anti-fungal Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-fungal Drugs Revenue, 2017-2028
  6.3.2 US Anti-fungal Drugs Market Size, 2017-2028
  6.3.3 Canada Anti-fungal Drugs Market Size, 2017-2028
  6.3.4 Mexico Anti-fungal Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-fungal Drugs Revenue, 2017-2028
  6.4.2 Germany Anti-fungal Drugs Market Size, 2017-2028
  6.4.3 France Anti-fungal Drugs Market Size, 2017-2028
  6.4.4 U.K. Anti-fungal Drugs Market Size, 2017-2028
  6.4.5 Italy Anti-fungal Drugs Market Size, 2017-2028
  6.4.6 Russia Anti-fungal Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-fungal Drugs Market Size, 2017-2028
  6.4.8 Benelux Anti-fungal Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-fungal Drugs Revenue, 2017-2028
  6.5.2 China Anti-fungal Drugs Market Size, 2017-2028
  6.5.3 Japan Anti-fungal Drugs Market Size, 2017-2028
  6.5.4 South Korea Anti-fungal Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-fungal Drugs Market Size, 2017-2028
  6.5.6 India Anti-fungal Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-fungal Drugs Revenue, 2017-2028
  6.6.2 Brazil Anti-fungal Drugs Market Size, 2017-2028
  6.6.3 Argentina Anti-fungal Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-fungal Drugs Revenue, 2017-2028
  6.7.2 Turkey Anti-fungal Drugs Market Size, 2017-2028
  6.7.3 Israel Anti-fungal Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-fungal Drugs Market Size, 2017-2028
  6.7.5 UAE Anti-fungal Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Anti-fungal Drugs Major Product Offerings
  7.1.4 Abbott Laboratories Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Astellas Pharma
  7.2.1 Astellas Pharma Corporate Summary
  7.2.2 Astellas Pharma Business Overview
  7.2.3 Astellas Pharma Anti-fungal Drugs Major Product Offerings
  7.2.4 Astellas Pharma Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.2.5 Astellas Pharma Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Anti-fungal Drugs Major Product Offerings
  7.3.4 Bayer Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Anti-fungal Drugs Major Product Offerings
  7.4.4 GlaxoSmithKline Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline Key News
7.5 Glenmark
  7.5.1 Glenmark Corporate Summary
  7.5.2 Glenmark Business Overview
  7.5.3 Glenmark Anti-fungal Drugs Major Product Offerings
  7.5.4 Glenmark Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.5.5 Glenmark Key News
7.6 Kramer Laboratories
  7.6.1 Kramer Laboratories Corporate Summary
  7.6.2 Kramer Laboratories Business Overview
  7.6.3 Kramer Laboratories Anti-fungal Drugs Major Product Offerings
  7.6.4 Kramer Laboratories Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.6.5 Kramer Laboratories Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Anti-fungal Drugs Major Product Offerings
  7.7.4 Merck Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Anti-fungal Drugs Major Product Offerings
  7.8.4 Novartis Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Anti-fungal Drugs Major Product Offerings
  7.9.4 Pfizer Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 SCYNEXIS
  7.10.1 SCYNEXIS Corporate Summary
  7.10.2 SCYNEXIS Business Overview
  7.10.3 SCYNEXIS Anti-fungal Drugs Major Product Offerings
  7.10.4 SCYNEXIS Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.10.5 SCYNEXIS Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Business Overview
  7.11.3 Sanofi Anti-fungal Drugs Major Product Offerings
  7.11.4 Sanofi Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.11.5 Sanofi Key News
7.12 Gilead Science
  7.12.1 Gilead Science Corporate Summary
  7.12.2 Gilead Science Business Overview
  7.12.3 Gilead Science Anti-fungal Drugs Major Product Offerings
  7.12.4 Gilead Science Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.12.5 Gilead Science Key News
7.13 Enzon Pharmaceuticals
  7.13.1 Enzon Pharmaceuticals Corporate Summary
  7.13.2 Enzon Pharmaceuticals Business Overview
  7.13.3 Enzon Pharmaceuticals Anti-fungal Drugs Major Product Offerings
  7.13.4 Enzon Pharmaceuticals Anti-fungal Drugs Revenue in Global Market (2017-2022)
  7.13.5 Enzon Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-fungal Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-fungal Drugs Market Drivers in Global Market
Table 3. Anti-fungal Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-fungal Drugs in Global Market
Table 5. Top Anti-fungal Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-fungal Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-fungal Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-fungal Drugs Product Type
Table 9. List of Global Tier 1 Anti-fungal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-fungal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-fungal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-fungal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-fungal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-fungal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-fungal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-fungal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-fungal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-fungal Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-fungal Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Anti-fungal Drugs Product Offerings
Table 32. Abbott Laboratories Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Astellas Pharma Corporate Summary
Table 34. Astellas Pharma Anti-fungal Drugs Product Offerings
Table 35. Astellas Pharma Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Anti-fungal Drugs Product Offerings
Table 38. Bayer Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Anti-fungal Drugs Product Offerings
Table 41. GlaxoSmithKline Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Glenmark Corporate Summary
Table 43. Glenmark Anti-fungal Drugs Product Offerings
Table 44. Glenmark Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Kramer Laboratories Corporate Summary
Table 46. Kramer Laboratories Anti-fungal Drugs Product Offerings
Table 47. Kramer Laboratories Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Anti-fungal Drugs Product Offerings
Table 50. Merck Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Anti-fungal Drugs Product Offerings
Table 53. Novartis Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Anti-fungal Drugs Product Offerings
Table 56. Pfizer Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 57. SCYNEXIS Corporate Summary
Table 58. SCYNEXIS Anti-fungal Drugs Product Offerings
Table 59. SCYNEXIS Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Anti-fungal Drugs Product Offerings
Table 62. Sanofi Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Gilead Science Corporate Summary
Table 64. Gilead Science Anti-fungal Drugs Product Offerings
Table 65. Gilead Science Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Enzon Pharmaceuticals Corporate Summary
Table 67. Enzon Pharmaceuticals Anti-fungal Drugs Product Offerings
Table 68. Enzon Pharmaceuticals Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-fungal Drugs Segment by Type in 2021
Figure 2. Anti-fungal Drugs Segment by Application in 2021
Figure 3. Global Anti-fungal Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-fungal Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-fungal Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-fungal Drugs Revenue in 2021
Figure 8. By Type - Global Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 12. US Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 24. China Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Astellas Pharma Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glenmark Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kramer Laboratories Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. SCYNEXIS Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sanofi Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Gilead Science Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Enzon Pharmaceuticals Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)